US Patent Issued to AiCella on Sept. 1 for "Using machine learning to predict cell therapy characteristics" (California Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,725,688, issued on Sept. 1, was assigned to AiCella Inc. (San Diego).

"Using machine learning to predict cell therapy characteristics" was invented by Geoffrey Stephens (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are systems and methods for improving processes for developing cell therapies by applying machine learning to data including manufacturing process data and clinical measurements (e.g., patient response and treatment data) to determine parameters and settings for a manufacturing process for engineering cells for use in cell therapy. Parameters and settings for a manufacturing process for genetically engineered T-cells inc...